RECURSION PHARMACEUTICALS, INC. — All Filings
882 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B3
424B4
424B5
424B7
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PREM14A
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002160 | Mar 27, 2026 | — |
| 8-K | 8-K | 0001601830-26-000054 | Mar 25, 2026 | — |
| 4 | FORM 4 | 0001601830-26-000052 | Mar 25, 2026 | Mar 23, 2026 |
| 144 | — | 0001959173-26-002556 | Mar 23, 2026 | — |
| 4 | FORM 4 | 0001712276-26-000002 | Mar 18, 2026 | Mar 16, 2026 |
| 144 | — | 0001959173-26-002399 | Mar 17, 2026 | — |
| 4 | FORM 4 | 0001601830-26-000049 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | FORM 4 | 0001601830-26-000048 | Mar 11, 2026 | Mar 9, 2026 |
| 144 | — | 0001628280-26-015905 | Mar 9, 2026 | — |
| 4 | FORM 4 | 0001601830-26-000045 | Mar 4, 2026 | Mar 3, 2026 |
| 144 | — | 0001959173-26-001784 | Mar 3, 2026 | — |
| S-8 | S-8 | 0001601830-26-000043 | Feb 25, 2026 | — |
| 424B5 | 424B5 | 0001601830-26-000041 | Feb 25, 2026 | — |
| 10-K | 10-K | 0001601830-26-000039 | Feb 25, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001601830-26-000038 | Feb 25, 2026 | — |
| 4 | FORM 4 | 0001601830-26-000022 | Feb 19, 2026 | Feb 17, 2026 |
| 4 | FORM 4 | 0001601830-26-000021 | Feb 19, 2026 | Feb 17, 2026 |
| 4 | FORM 4 | 0001601830-26-000020 | Feb 19, 2026 | Feb 17, 2026 |
| 4 | FORM 4 | 0001601830-26-000019 | Feb 19, 2026 | Feb 17, 2026 |
| 144 | — | 0001959173-26-001195 | Feb 19, 2026 | — |
| 144 | — | 0001959173-26-001109 | Feb 18, 2026 | — |
| 4 | FORM 4 | 0001601830-26-000014 | Feb 10, 2026 | Feb 6, 2026 |
| 4 | FORM 4 | 0001601830-26-000013 | Feb 10, 2026 | Feb 6, 2026 |
| 4 | FORM 4 | 0001601830-26-000012 | Feb 10, 2026 | Feb 6, 2026 |
| 4 | FORM 4 | 0001601830-26-000008 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | FORM 4 | 0001601830-26-000007 | Feb 6, 2026 | Feb 3, 2026 |
| SCHEDULE 13G/A | — | 0001088875-26-000005 | Feb 5, 2026 | — |
| 144 | — | 0001959173-26-000607 | Feb 4, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-009588 | Feb 3, 2026 | — |
| 144 | — | 0001959173-26-000567 | Feb 3, 2026 | — |
| 4 | FORM 4 | 0001856369-26-000005 | Jan 22, 2026 | Jan 20, 2026 |
| 144 | — | 0001959173-26-000360 | Jan 20, 2026 | — |
| 8-K | 8-K | 0001601830-26-000002 | Jan 12, 2026 | — |
| 3 | FORM 3 | 0002006495-26-000008 | Jan 9, 2026 | Jan 1, 2026 |
| 4 | FORM 4 | 0001856094-26-000002 | Jan 8, 2026 | Jan 6, 2026 |
| 4 | FORM 4 | 0001856369-26-000003 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001852075-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001837016-26-000003 | Jan 6, 2026 | Jan 2, 2026 |
| 144 | — | 0001959173-26-000126 | Jan 6, 2026 | — |
| 144 | — | 0001959173-26-000071 | Jan 5, 2026 | — |
| 4 | FORM 4 | 0001712276-25-000017 | Dec 30, 2025 | Dec 29, 2025 |
| 4 | FORM 4 | 0001601830-25-000176 | Dec 29, 2025 | Dec 22, 2025 |
| 144 | — | 0001959173-25-007926 | Dec 29, 2025 | — |
| SCHEDULE 13D/A | — | 0001999371-25-021183 | Dec 23, 2025 | — |
| 144 | — | 0001628280-25-058427 | Dec 22, 2025 | — |
| 4 | FORM 4 | 0001856369-25-000018 | Dec 19, 2025 | — |
| 144 | — | 0001959173-25-007842 | Dec 19, 2025 | — |
| 4 | FORM 4 | 0001712276-25-000015 | Dec 17, 2025 | Dec 15, 2025 |
| 8-K | 8-K | 0001601830-25-000174 | Dec 8, 2025 | — |
| 4 | FORM 4 | 0001856369-25-000016 | Dec 5, 2025 | Dec 4, 2025 |